Trials / Unknown
UnknownNCT03740672
Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline
Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline in Chinese Patients of Gynecologic Malignancies
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (estimated)
- Sponsor
- Lei Li · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- —
Summary
This study aims to investigate the adherence to the antiemesis NCCN guideline in Chinese patients of gynecologic malignancies, who are given chemotherapy treatment. The risk of chemotherapy induced nausea and vomiting (CINV) is calculated by the questionnaire supported by the website "CINV Risk Assessment" (http://www.riskcinv.org/).
Conditions
Timeline
- Start date
- 2018-11-22
- Primary completion
- 2019-12-01
- Completion
- 2019-12-01
- First posted
- 2018-11-14
- Last updated
- 2018-11-26
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03740672. Inclusion in this directory is not an endorsement.